Knockout of beta(1)- and beta(2)-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis
- PMID: 18193078
- PMCID: PMC2259198
- DOI: 10.1038/sj.bjp.0707622
Knockout of beta(1)- and beta(2)-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis
Abstract
Background and purpose: The role of beta-adrenoceptors in heart disease remains controversial. Although beta-blockers ameliorate the progression of heart disease, the mechanism remains undefined. We investigated the effect of beta-adrenoceptors on cardiac hypertrophic growth using beta(1)- and beta(2)-adrenoreceptor knockout and wild-type (WT) mice.
Experimental approach: Mice were subjected to aortic banding or sham surgery, and their cardiac function was determined by echocardiography and micromanometry.
Key results: At 4 and 12 weeks after aortic banding, the left ventricle:body mass ratio was increased by 80-87% in wild-type mice, but only by 15% in knockouts, relative to sham-operated groups. Despite the blunted hypertrophic growth, ventricular function in knockouts was maintained. WT mice responded to pressure overload with up-regulation of gene expression of inflammatory cytokines and fibrogenic growth factors, and with severe cardiac fibrosis. All these effects were absent in the knockout animals.
Conclusion and implications: Our findings of a markedly attenuated cardiac hypertrophy and fibrosis following pressure overload in this knockout model emphasize that beta-adrenoceptor signalling plays a central role in cardiac hypertrophy and maladaptation following pressure overload.
Figures
Similar articles
-
Pressure overload causes cardiac hypertrophy in beta1-adrenergic and beta2-adrenergic receptor double knockout mice.J Hypertens. 2006 Mar;24(3):563-71. doi: 10.1097/01.hjh.0000203843.41937.2a. J Hypertens. 2006. PMID: 16467660
-
Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state.Circulation. 2007 Mar 20;115(11):1398-407. doi: 10.1161/CIRCULATIONAHA.106.643585. Epub 2007 Mar 12. Circulation. 2007. PMID: 17353445
-
Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload.J Am Coll Cardiol. 2006 Feb 21;47(4):817-26. doi: 10.1016/j.jacc.2005.09.051. Epub 2006 Jan 26. J Am Coll Cardiol. 2006. PMID: 16487851
-
Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.Clin Exp Pharmacol Physiol. 2009 Nov;36(11):1054-61. doi: 10.1111/j.1440-1681.2009.05243.x. Epub 2009 Jun 29. Clin Exp Pharmacol Physiol. 2009. PMID: 19566828
-
Liganded vitamin D receptor displays anti-hypertrophic activity in the murine heart.J Steroid Biochem Mol Biol. 2013 Jul;136:150-5. doi: 10.1016/j.jsbmb.2012.09.007. Epub 2012 Sep 16. J Steroid Biochem Mol Biol. 2013. PMID: 22989481 Review.
Cited by
-
Internalized β2-Adrenergic Receptors Oppose PLC-Dependent Hypertrophic Signaling.Circ Res. 2024 Jul 5;135(2):e24-e38. doi: 10.1161/CIRCRESAHA.123.323201. Epub 2024 May 30. Circ Res. 2024. PMID: 38813686
-
The potential roles of exosomes in pathological cardiomyocyte hypertrophy mechanisms and therapy: A review.Medicine (Baltimore). 2024 Apr 26;103(17):e37994. doi: 10.1097/MD.0000000000037994. Medicine (Baltimore). 2024. PMID: 38669371 Free PMC article. Review.
-
Decrease in heart adrenoceptor gene expression and receptor number as compensatory tool for preserved heart function and biological rhythm in M(2) KO animals.Naunyn Schmiedebergs Arch Pharmacol. 2012 Dec;385(12):1161-73. doi: 10.1007/s00210-012-0800-9. Epub 2012 Oct 24. Naunyn Schmiedebergs Arch Pharmacol. 2012. PMID: 23093370
-
Chronic activation of the low affinity site of β1-adrenoceptors stimulates haemodynamics but exacerbates pressure-overload cardiac remodelling.Br J Pharmacol. 2013 Sep;170(2):352-65. doi: 10.1111/bph.12272. Br J Pharmacol. 2013. PMID: 23750586 Free PMC article.
-
Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy.Diabetes. 2010 Jun;59(6):1512-20. doi: 10.2337/db09-1456. Epub 2010 Mar 9. Diabetes. 2010. PMID: 20215428 Free PMC article.
References
-
- Antos CL, Frey N, Marx SO, Reiken S, Gaburjakova M, Richardson JA, et al. Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase A. Circ Res. 2001;89:997–1004. - PubMed
-
- Bernstein D. Cardiovascular and metabolic alterations in mice lacking β1- and β2-adrenergic receptors. Trends Cardiovasc Med. 2002;12:287–294. - PubMed
-
- Bernstein D, Fajardo G, Zhao M, Urashima T, Powers J, Berry G, et al. Differential cardioprotective/cardiotoxic effects mediated by β-adrenergic receptor subtypes. Am J Physiol Heart Circ Physiol. 2005;289:H2441–H2449. - PubMed
-
- Brede M, Wiesmann F, Jahns R, Hadamek K, Arnolt C, Neubauer S, et al. Feedback inhibition of catecholamine release by two different α2-adrenoceptor subtypes prevents progression of heart failure. Circulation. 2002;106:2491–2496. - PubMed
-
- Brum PC, Kosek J, Patterson A, Bernstein D, Kobilka B. Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice. Am J Physiol Heart Circ Physiol. 2002;283:H1838–H1845. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources